Publikationen zur Dialyse

Neyer U.
Nephrologie und Dialyse in Vorarlberg
Wiener Klinische Wochenschrift. Volume 127, Issue 2 June 2015 Springer-Med

Zitt E, Sturm G, Kronenberg F, Neyer U, Knoll F, Lhotta K, Weiss G.
Iron supplementation and mortality in incident dialysis patients: an observational study
PLoS One. 2015 Dec 14;9(12):e114144. doi: 10.1371/journal.pone.0114144. eCollection 2014. Pub-Med

Pronai W, Neyer U, Barnas U, Wieser C, Jaeger C, Dekic D, Hemetsberger M, Rosenkranz AR.
Darbepoetin alfa once every 2 weeks effectively maintained hemoglobin in dialysis patients in an observational study: Austrian cohort of ALTERNATE
Wien Med Wochenschr. 2014 Mar;164(5-6):109-19. doi: 10.1007/s10354-013-0256-7. Epub 2014 Jan 31. Pub-Med

Schwaiger JP, Nakada Y, Berberich R, Ikewaki K, Dieplinger B, Zitt E, Neyer U, Salmhofer H, Kronenberg F, Koenig P, Dieplinger H.
Lipoprotein kinetics in male hemodialysis patients treated with atorvastatin
Clin J Am Soc Nephrol. 2013 Aug;8(8):1319-26. doi: 10.2215/CJN.10881012. Epub 2013 Apr 18.Pub-Med

Watschinger B, Salmhofer H, Horn S, Neyer U, Wiesinger T, Wiesholzer M, Erb H, Jaeger C, Hemetsberger M, Rosenkranz AR.
The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin
Wien Klin Wochenschr. 2013 Feb;125(3-4):71-82. doi: 10.1007/s00508-012-0311-1. Epub 2013 Jan 9. Pub-Med

EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS.
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis
N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3. Pub-Med

Zitt E, Sprenger-Mähr H, Knoll F, Neyer U, Lhotta K.
Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease.
Vaccine. 2012 Jan 20;30(5):931-5. doi: 10.1016/j.vaccine.2011.11.086. Epub 2011 Dec 4. Pub-Med

Zitt E, Neyer U.
Management of Secondary Hyperparathyroidism in Hemodialysis Patients
Progress in Hemodialysis - From Emergent Biotechnology to Clinical Practice
ISBN 978-953-307-377-4
 intechopen.com

Zitt E, Lamina C, Sturm G, Knoll F, Lins F, Freistätter O, Kronenberg F, Lhotta K, Neyer U.
Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients
Clin J Am Soc Nephrol. 2011 Nov;6(11):2650-6. Epub 2011 Sep 8. Pub-Med

Knoll F, Sturm G, Lamina C, Zitt E, Lins F, Freistätter O, Kronenberg F, Lhotta K, Neyer U.
Coumarins and survival in incident dialysis patients
Nephrol Dial Transplant. 2011 Jul 18. Pub-Med

Sturm G, Lamina C, Zitt E, Lhotta K, Haider F, Neyer U, Kronenberg F.
Association of HbA1c values with mortality and cardiovascular events in diabetic dialysis patients. The INVOR study and review of the literature
Clin PLoS One. 2011;6(5):e20093. Epub 2011 May 18. Review. Pub-Med

Zitt E, Kirsch AH, Haueis M, Strasak A, Neyer U, Mayer G, Rosenkranz AR.
The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients
Clin Nephrol. 2011 Apr;75(4):309-18. Pub-Med

Gouya G, Sturm G, Lamina C, Zitt E, Freistätter O, Struck J, Wolzt M, Knoll F, Lins F, Lhotta K, Neyer U, Kronenberg F.
The association of mid-regional pro-adrenomedullin and the mid-regional pro-atrial natriuretic peptide with mortality in an incident dialyse cohort
PLoS One. 2011 Mar 7;6(3):e17803. Pub-Med

Spanaus KS, Kollerits B, Ritz E, Hersberger M, Kronenberg F, von Eckardstein A; Mild and Moderate Kidney Disease (MMKD) Study Group.
Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease.
Clin Chem. 2010 May;56(5):740-9. Epub 2010 Mar 11. Pub-Med

Sturm G, Lamina C, Zitt E, Lhotta K, Lins F, Freistätter O, Neyer U, Kronenberg F.
Sex-specific association of time-varying haemoglobin values with mortality in incident dialysis patients
Nephrol Dial Transplant. 2010 Aug;25(8):2715-22. Epub 2010 Feb 26. Pub-Med

Haag-Weber M, Vetter A, Thyroff-Friesinger U; INJ-Study Group.
Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysis
Clin Nephrol. 2009 Nov;72(5):380-90. Pub-Med

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
N Engl J Med. 2009 Apr 2;360(14):1395-407. Epub 2009 Mar 30 Pub-Med

Prischl FC, Knoll F, Kramar R.
Another peritioneal dialysis catheter encapsulated in peritoneal tissue
Perit Dial Int., 2009 Jan-Feb; 29(1):119-20

Zitt E, Neyer U, Meusburger E, Tiefenthaler M, Kotanko P, Mayer G, Rosenkranz AR
Effect of dialysate temperature and diabetes on autonomic cardiovascular regulation during hemodialysis
Kidney Blood Press Res. 2008;31(4):217-25. Epub 2008 Jun 28 Pub-Med

Ulrich Neyer, Gisela Sturm, Friederike Lins, Otto Freistätter, Florian Kronenberg, Karl Lhotta
Study of Incident Dialysis Patients in Vorarlberg (INVOR)
VIVIT (Vorarlberg Institute for Vascular Investigation and Treatment ) 2008 Okt 10 Vivit

Roshdi Nadyah
Wundmanagement in der Dialyse am Beispiel des diabetischen Fußsyndroms.
Österreichische Gesellschaft für vaskuläre Pflege, 2008 Juni oegvp

Pescoll Clemens
Der permanente zentralvenöse Gefäßzugang (PermKath)in der Dialyse
Österreichische Gesellschaft für vaskuläre Pflege, 2008 Juni oegvp

Sturm G, Kollerits B , Neyer U , Ritz E , Kronenberg F; for the MMKD study group
Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study
Exp Gerontol. 2008; 43 :347-352 Pub-Med

Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F;
Fibroblast Growth Factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD)Study.
Am Soc Nephrol. 2007; 18: 2601- 8 Med

Joannidis M, Rauchenzauner M, Leiner B, Rosenkranz A, Ebenbichler CF, Laimer M, Tatarczyk T,Meusburger E, Mayer G
Effect of intradialytic parenteral nutrition in patients with malnutrition-inflammation complex syndrome on body weight, inflammation, serum lipids and adipocytokines: results form a pilot study
EurJ Clin Nutr 2007 Med

Neyer U
Risikofaktor Hyperphosphatämie
Nephro Script 2007; 10/1: 4

Zitt N, Kollerits B, Neyer U, Mark W, Heininger D, Mayer G, Kronenberg F, Lhotta K.
Cigarette smoking aggravates microvascular pathology in renal allografts.
Nephrol Dial Transplant 2007; 22(10):3034 - 9 Med

Zitt E, Haid A, Köberle-Wührer R, Sprenger-Mähr H, Hörandner H, Zimmermann G, Neyer U
Langzeitbeobachtung nach Parathyreoidektomie mit Autotransplantation von selektioniertem Nebenschilddrüsengewebe bei chronischen Dialysepatienten.
Nieren- und Hochdruckkrankheiten, 2007; 36: 87 - 95

Risch L, Saely C, Neyer U, Hoefle G, Gouya G, Zerlauth M, Risch G M, Risch M, Drexel H
Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care-an evaluation using ISDM-traceable MDRD as well as Mayo Clinic quadratic equation estimates.
Clin Cim Acta 2007; 378: 71-7 Med

Zitt E, Rosenkranz A, Neyer U
Serologische Diagnostik der renalen Osteodystrophie
Nephro Script 2006; 9. Jahrgang Nr.4: 18-23

Risch L, Neyer U
Alternative zum Kreatinin in der GFR-Abschätzung, Cystatin C zur Bestimmung der Nierenfunktion.
Nephro Script 2006; 9. Jahrgang Nr.3: 18-24

Hörandner H, Neyer U
Die Verhinderung des fulminanten Rezidivs nach Parathyreoidektomie durch makroskopische intraoperative Gewebsauswahl / Typisierung.
Nieren- und Hochdruckkrankheiten 2006; 35: 262-8

Lingenhel A, Lhotta K, Neyer U, Heid I M, Rantner B, Kronenberg M F, König P, von Eckardstein A, Schober M,Dieplinger H, Kronenberg F
Role of the kidney for the metabolism of apolipoprotein A-IV: influence of the type of proteinuria.
J Lipid Res 2006; 47: 2071-9 Med

Schwaiger J P, Neyer U, Sprenger-Mähr H, Kollerits B, Mündle M, Längle M, Kronenberg F
A simple score predicts future cardiovascular events in an inception cohort of dialysis patients.
Kidney Int 2006; 70: 543-8 Med

Schwaiger J P, Lamina C, Neyer U, König P, Kathrein H, Sturm W, Lhotta K, Gröchenig E, Dieplinger H, Kronenberg F
Carotid plaques and their predictive value for cardiovascular disease an all-cause mortality in hemodialysis patients considering renal transplantation: a decade follow-up.
Am J Kidney Dis 2006; 47: 888-97 Pub - Med

Boes E , Fliser D , Ritz E , König P , Lhotta K , Mann J F , Muller GA , Neyer U , Riegel W , Riegler P , Kronenberg F
Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.
J Am Soc Nephrol 2006; 17: 528-36 Med

Mähr N, Neyer U, Prischl F, Kramar R, Mayer G,Kronenberg F, Lhotta K
Proteinuria and hemoglobin levels in patients with primary glomerular disease.
Am J Kidney Dis 2005; 46: 424-31 Med

Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtlander T, Auinger M, Demmelbauer K, Lorenz M, Hauser A C, Kofler H J, Lhotta K, Neyer U, Pronai W, Wallner M, Wieser C, Wiesholzer M, Zodl H, Fodinger M, Sunder-Plassmann G
Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.
J Am Soc Nephrol 2004; 15: 1323-9 Med

Koller H, Zitt E, Staudacher G, Neyer U, Mayer G, Rosenkranz A
Variable parathyroid hormone (1-84)/carboxyl-terminal PTH ratios detected by four novel parathyroid hormone assays.
Clin Nephrol 2004; 61: 337-43 Med

Neyer U, Hörandner H
Parathyroidectomy in renal hyperparathyroidism.
3th Congress of Nephrology in Internet http://www.uninet.edu/cin2003/conf/neyer/neyer.html

Hörandner H, Neyer U
The regional classification of parathyroid tissue as used for tissue selection prior to autotransplantation. 3th Congress ofNephrology in Internet http://www.uninet.edu/cin2003/conf/horandner/horandner.html

Neumann H P, Salzmann M, Iwan-Bohnert B, Mannuelian T, Skerka C, Lenk D, Bender B U, Cybulla M, Konigsrainer A, Neyer U, Bock A, Widmer U, Male D A, Franke G, Zipfel P F
Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.
J Med Genet 2003; 40: 676-81 Med

Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G
Effect of iron treatment on circulatin cytokine levels in ESRD patients receiving recombinant human erythropoietin.
Kidney Int 2003; 64: 572-78 Med

Kronenberg F, Lingenhel A, Neyer U, Lhotta K, König P, Auinger M, Wiesholzer M, Andersson H, Dieplinger H
Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients.
Kidney Int 2003; 63: 84: 113-16 Med

Kronenberg F, Mündle M, Längle M, Neyer U
Prevalence and progression of peripheral arterial calcifications in patients with ESRD.
Am J Kidney Dis 2003; 41: 140-8 Med

Haas M, Mayer G, Wirnsberger G, Holzer H, Ratschek M, Neyer U, Neuweiler J, Kramar R, Schneider B, Breiteneder-Geleff S, Regele H, Hörl W, Kerjaschki D
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: A pilot study
Wien Klin Wochenschr 2002; 114: 143-47 Med

Neyer U, Hörandner H, Haid A, Zimmermann G, Niederle B
Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection.
Nephrol Dial Transplant 2002; 17: 625-29 Med

Kronenberg F, Kuen E, Ritz E, König P, Kraatz G, Lhotta K, Mann J, Muller G, Neyer U, Riegel W, Riegler P, Schwenger V, von Eckardstein A
Apoliporotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure.
J Am Soc Nephrol 2002; 13: 461-9 Pub-Med

Mann J F, Muller G A, Neyer U, Riegel W, Schwenger V, Riegler O, Selhub J
Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate.
Atherosclerosis 2001; 159: 219-23

Bostom A, Kronenberg F, Jacues P, Kuen E, Ritz E, König P, Kraatz G, Lhotta K, Mann J, Muller G, Neyer U, Riegel W, Schwenger V, Riegler O, Selhub J
Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate.
Atherosclerosis 2001; 159: 219-23 Med

Bostom A, Kronenberg F, Gohh R, Schwenger V, Kuen E, König P, Kraatz G, Lhotta K, Mann J, Muller G, Neyer U, Riegel W, Riegler P, Rietz E, Selhub J
Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency.
Atherosclerosis 2001; 156: 227-30 Med

Hörandner H, Murzl E, Neyer U, Breiteneder-Geleff S, Niederle B, Haid A, Breitfellner G Focal proliferation in reactive hyperplastic parathyroid tissue in end-stage renal failure-implication for autotransplantation after total parathyroidectomy.
Wien Klin Wochenschr 2000; 112: 353-57 Med

Kronenberg F, Kuen E, Ritz E, Junker R, König P, Kraatz G, Lhotta K, Mann J, Müller G, Neyer U, Riegel W, Riegler P, Schwenger V, Eckardstein v A
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
J Am Soc Nephrol 2000; 11: 105-15 Med

Neyer U
Neue diagnostische und therapeutische Möglichkeiten beim sekundären Hyperparathyreoidismus.
Nephroscript 2000; 3: 4-6

Kerschdorfer L, König P, Neyer U, Bösmüller C, Lhotta K, Auinger M, Hohenegger M, Riegler P, Margreiter R, Utermann G, Dieplinger H, Kronenberg F
Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up.
Atherosclerosis 1999; 144: 381-91 Med

Fuchs W, Wolber T, Wöß E, Neyer U, Drexel H
Leptospirose mit akutem Nierenversagen, schwerem Ikterus, disseminierten Blutungen und Xanthopsie.
Schweiz Med Wochenschr 1999; 129: 847-50 Pub-Med

Kronenberg F, Neyer U, Lhotta K, Trenkwalder E, Auinger M, Pribasnig A, Meisl T, König P, Dieplinger H
The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up.
J Am Soc Nephrol 1999; 10: 1027-36 Med

Köberle-Wührer R, Haid A, Sprenger-Mähr H, Köberle D, Meusburger E, Neyer U
Stellenwert der intraoperativen Blutabnahme zur Parathormonbestimmung während totaler Parathyreoidektomie mit Autotransplantation bei Patienten mit renalem Hyperparathyreoidismus.
Wien Klin Wochenschr 1999; 111: 246-50 Med

Haas M, Yilmaz N, Schmidt A, Neyer U et al
Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric und systemic hemodynamic effect of Enalapril in patients with proteinuric renal disease.
Kidney Blood Press Res 1998; 21: 66-69 Pub-Med

Kronenberg F, Trenkwalder E, Sturm W, Kathrein H, König P, Neyer U, Gröchenig E, Utermann G, Dieplinger H
LDL-unbound apolipoprotein (a) and carotid atherosclerosis in hemodialysis patients.
Clin Genet 1997;52 Med

König P, Lhotta K, Neyer U, Stegmayr B
Kontinuierliche ambulante Peritonealdialyse als Überbrückung zur Herztransplantation.
Nieren- und Hochdruckkrankheiten 1997; 1: 55-59

Hörandner H, Neyer U, Gruber U, Zimmermann G, Haid A, Niederle B
Pathomorphologie von autotransplantiertem Nebenschilddrüsengewebe: Indiz für Progression oder Regression des fortgeschrittenen sekundären Hyperparathyreoidismus.
Nieren- und Hochdruckkrankheiten 1997; 26: 319-27

Haid A, Neyer U, Zimmermann G
Transitory implantectomy - Experiences with the Casanova-technique.
Acta Chir Austr 1996; 124: 63-65

Eisterer W, Neyer U, Hilbe W, Diem G, Öhlschlegel C, Ludescher C, Thaler J
Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia.
Nephron 1996; 72: 468-71 Med

Kronenberg F, König P, Neyer U, Auinger M, Pribasnig A, Meisl T, Pinter G,
Dieplinger H
Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study.
Thrombosis and Haemostasis 1995; 74: 1025-8 Pub-Med

Hergan K, Neyer U, Doringer W, Mündle M
MR Imaging in graft-dependent recurrent hyperparathyroidism after parathyroidectomy and autotransplantation.
JMRI 1995; 5: 541-44 Pub-Med

Kronenberg F, König P, Neyer U, Auinger M, Pribasnig A, Lang U, Reitinger J, Pinter G, Utermann G, Dieplinger H
Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
J Am Soc Nephrol 1995; 6: 110-20 Med

Neyer U, Wöss E, Drexel H
Niedrig dosierte intravenöse Calcitriol-Bolus-Therapie bei chronischen Hämodialysepatienten.
Acta medicia Austriaca 1994; 21: 129-32 Med

Lhotta K, Vogel W, Meisl T, Buxbaum M, Neyer U, Sandholzer C, König P
Alpha 1-Antitrypsin phenotypes in patients with c-ANCA positive vasculitis.
Clin Sci 1994; 87: 693-95 Med

Kronenberg F, Kathrein H, König P, Neyer U, Sturm W, Lhotta K, Gröchenig E, Utermann G, Dieplinger H
Apolipoprotein (a), phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.
Arteriosclerosis and Thromb 1994; 4: 1311-405 Pub-Med

König P, Vogel W, Umlauft F, Weyrer K, Promegger R, Lhotta K, Neyer U, Stummvoll K, Grünewald K
Interferon treatment for chronic hepatitis C virus infection in uremic patients.
Kidney Int 1994; 45: 1507-9 Med

Neyer U, Wöss E, Neuweiler J
Wegener's granulomatosis associated with silicosis.
Nephr Dial Transplant 1994; 9: 559-61 Med

Zimmermann G, Neyer U, Haid A, Wöss E, Hörandner H, Breitfellner G
Erfahrungen mit der totalen Parathyreoidektomie und Autotransplantation intraoperativ ausgewählten Parathyreoidea-Gewebes beim reaktiven renalen Hyperparathyreoidismus.
Wien Klin Wochenschr 1992; 104: 434-38 Med

Austrian Multicenter Study Group (Graf H, Neyer U et al):
Effectivness and safety of recombinant human Erythropoietin in predialysis patients.
Nephron 1992; 61: 1-5 Med

Hausmann N, Neyer U, Hämmerle W
Akut rezidivierende Uveitis und idiopathische interstitielle Nephritis - eine nosologische Einheit (TINU-Syndrom).
Klin Mbl Augenheilk 1988; 193: 35-8 Med

Wöß E, Neyer U
Hypersensitivitätsangiitis nach Allopurinol-Therapie.
Fortschr Med 1988; 106: 730-31 Med

Sprenger R, Neyer U
Enterococcus-Peritonitis after endoscopic polypectomy.
Perit Dial Bull 1987; 7: 263

Neyer U, Frick H, Reiter A
Bicarbonatdialyse bei schwerer akzidenteller Hypothermie mit Rhabdomyolyse.
Intensivbehandlung 1987; 12: 161-63

Mähr G, Knittel B, Lorünser B, Neyer U, Risch G
Amylase und Lipase als differentialdiagnostische Bezugsgröße bei chronischem Nierenversagen und Pankreatitis.
Acta med Austriaca 1985; 12: 51 Med

Neyer U, Wöss E, Bürgin M, Hofmann E, Möst J
Nephrotisches Syndrom und akute interstitielle Nephritis nach Phenylbutazon.
Schweiz Med Wochenschr 1985; 115: 1551 Pub-Med

Horak W, Kemensi W, Brandstätter R, Brunnthaler K, Dorda W, Neyer U et al
HTLV-III-Antikörper bei Risikogruppen in Österreich.
Wien Klin Wochenschr 1985; 97: 672

Sprenger R, Neyer U, Dirschmid K
Kolitis bei kontinuierlicher ambulanter Peritonealdialyse (CAPD).
Nieren- und Hochdruckkrankheiten 1985; 14: 190

Neyer U, Wöss E, Haller R, Kröss R
Kopfschmerzen und EEG-Veränderungen unter Acetat- und Bicarbonatdialyse.
Acta med Austriaca 1983; 1: 15 Med

Bürgin M, Neyer U, Kostner G
Lipidose mésangiale associée a une polycorie cholestérolique.
Nephrologie 1982; 3: 124 Med

Neyer U, Wöss E
Erfolgreiche Antikoagulantienbehandlung bei bilateraler Nierenvenenthrombose.
Med Welt 1982; 33: 903

Neyer U, Dézsy J
Hepatitis B-Prophylaxe durch passive Immunisierung beim Dialysepersonal und Versuch einer Kosten-Nutzen-Analyse.
Österr Krankenhauszeitung 1981; 22: 75

Neyer U, Mähr G, Kiesler J, Bürgin M
Akutes Nierenversagen nach Rifampicinbehandlung.
Therapie der Gegenwart 1980; 119: 689 Med

Neyer U, Ell P, Mähr G, Meixner M, Gloor F
La centellografia en el diagnostico de la osteopathia renal.
Med Alemana 1979; 20: 215

Neyer U, Mähr G, Ell P, Meixner M, Gloor F
2Bone scans in the diagnosis of renal osteopathy.
Minerva Med 1978; 69: 3951-9 Pub-Med

Neyer U, Mähr G, Ell P, Meixner M, Gloor F
Die Knochenszintigraphie in der Diagnostik der renalen Osteopathie.
Dtsch Med Wochenschr 1978; 103: 451 Med

© Dialysestation Bregenz GmbH
Nideggegasse 12 | 6900 Bregenz | Österreich | T +43 (0)5574 87177 | E-Mail | Impressum
Dialyse Bregenz, Dialyse Vorarlberg
Dialyse Bregenz
Dialyse Bregenz